Myeloid-derived suppressor cells modulate B-cell responses

Highlights

• Myeloid-derived suppressor cells (MDSCs) are important mediators of the immune cells.

• MDSCs impair B-cell proliferation and induce B-cell death.

• MDSCs decrease B-cell IgM responses and down regulate the expression of important ctivation surface markers.

• MDSCs use of reactive oxygen species (ROS), arginase-1, and nitric oxide (NO) to modulate B-cell immune responses.

Abstract

Myeloid-derived suppressor cells (MDSCs) are key regulators of adaptive immunity by suppressing T-cell functions. However, their potential action on or interaction with B cells remained poorly understood. Here we demonstrate that human polymorphonuclear MDSCs differentially modulate B-cell function by suppressing B-cell proliferation and antibody production. We further demonstrate that this MDSC-mediated effect is cell contact dependent and involves established mediators such as arginase-1, nitric oxide (NO), reactive oxygen species (ROS) as well as B-cell death. Collectively, our studies provide novel evidence that human MDSCs modulate B cells, which could have future implications for immunotherapy approaches.

Introduction

Myeloid-derived suppressor cells (MDSCs) are innate immune cells that are functionally characterized by their capacity to dampen T-cell responses [1], [2]. Phenotypically, MDSCs are a heterogeneous population and comprise a neutrophilic/polymorphonuclear (PMN-MDSC) and a monocytic (M-MDSC) subset as defined by their respective surface marker profiles (Bronte et al., 2016). In humans, polymorphonuclear MDSCs represent the predominant subtype [3], [4] and have been studied in several forms of cancer as well as in infections, auto-immune and auto-inflammatory disease conditions [1], [5].

While initially MDSCs were found to suppress CD4⁺ and CD8⁺ T-cell responses, subsequent investigations expanded their role by demonstrating that MDSCs were also involved in the regulation of and interaction with natural killer (NK) cells, dendritic cells (DC), neutrophils, macrophages and natural killer T (NKT) cells [6], [7], [8]. The molecular and cellular mechanisms involved in MDSC generation and function seem to be diverse and complex, but major mediators described to be involved so far include arginase 1 activity (arginine deprivation), reactive oxygen species (ROS), nitric oxide synthase (NO), indoleamine 2,3-dioxygenase (IDO) and tumor necrosis factor alpha (TNF-α) [1], [5], [7], [8]. Recently, the transcriptional regulation and the proteome landscape of MDSCs have further deepened our insights into their generation, homeostasis and regulation [9], [10].

In spite of multiple MDSCs-immune cell interactions described [6], [7], [8], the potential role of MDSCs in regulating B cells, as key adaptive immune cell population, remained poorly understood. Several recent observations already suggested that MDSCs and B cells functionally interact in mice [11], [12], [13], [14], but the characteristics of human MDSCs-B-cell interactions and the underlying mechanisms have not been defined yet.

Here we demonstrate that human PMN-MDSCs differentially regulate key B-cell functions, particularly B-cell proliferation and antibody production, depending on the B-cell stimulus. We further demonstrate that this MDSC-mediated effect is cell contact dependent and involves arginase-1, NO, ROS and cell death.